A health-care worker in Lima, Peru, prepares to administer a dose of a messenger-RNA-based COVID-19 vaccine., vaccine makers quickly began developing shots against the highly mutated and transmissible virus. This week, pharmaceutical firm Pfizer and biotechnology company Moderna both announced that they had initiated clinical trials in which they are dosing people with Omicron-based vaccines.
The influenza group meets twice per year to recommend the composition of the next season’s vaccine, and national regulators and authorities typically follow the WHO’s guidance. So far, no such global structure exists for COVID-19. And until Omicron, it wasn’t needed. Vaccine makers based their initial COVID-19 jabs on the SARS-CoV-2 strain first detected in Wuhan, China. But the original virus’s biology differs notably from Omicron’s, which contains more than 30 mutations in key regions of its genome.
The protection provided by a booster also wanes quickly, studies show: UK data suggest that effectiveness against hospitalization drops from
Doesn't need!!
Given how well regular boosters do with it maybe not, but eventually we'll need updated boosters. It's probably better to do this now & figure out a framework of how to update the vaccine before we really need too.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
What’s the magic number for booster shots?COVID vaccine boosters are proving a useful tool against Omicron, but scientists say that endless boosting might not be a practical or sustainable strategy. Annual, with the flu shot Zero if they do not prevent transmission and infection. 42
Source: Nature - 🏆 64. / 68 Read more »
Source: verge - 🏆 94. / 67 Read more »
Source: TIMEHealth - 🏆 121. / 63 Read more »
Source: dallasnews - 🏆 18. / 71 Read more »